These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8973783)

  • 1. Hypertension, atherosclerosis and LVH in ELSA. European Lacidipine Study of Atherosclerosis.
    Agabiti Rosei E
    Blood Press Suppl; 1996; 4():44-7. PubMed ID: 8973783
    [No Abstract]   [Full Text] [Related]  

  • 2. Compliance studies in ELSA. European Lacidipine Study of Atherosclerosis.
    Giannattasio C; Boutouyrie P; Glen S; Mallion J; Reid J; Laurent S; Mancia G
    Blood Press Suppl; 1996; 4():39-43. PubMed ID: 8973782
    [No Abstract]   [Full Text] [Related]  

  • 3. Ambulatory blood pressure monitoring in the ELSA study. European Lacidipine Study on Atherosclerosis.
    Mancia G; Parati G; Omboni S; Ravogli A; Villani A; Santucciu C; Ulian L
    Blood Press Suppl; 1996; 4():36-8. PubMed ID: 8973781
    [No Abstract]   [Full Text] [Related]  

  • 4. Data collection and statistical analyses in ELSA. European Lacidipine Study on Atherosclerosis.
    Hennig M; Neiss A
    Blood Press Suppl; 1996; 4():24-9. PubMed ID: 8973779
    [No Abstract]   [Full Text] [Related]  

  • 5. [The preliminary clinical evidence from the ELSA study. The European Lacidipine Study on Atherosclerosis].
    Leonetti G
    Ann Ital Med Int; 1995 Oct; 10 Suppl():74S-77S. PubMed ID: 8562272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the benefits of an antihypertensive agent using trials based on event and organ damage: the Systolic Hypertension in the Elderly Long-term Lacidipine (SHELL) trial and the European Lacidipine Study on Atherosclerosis (ELSA).
    Zanchetti A
    J Hypertens Suppl; 1995 Dec; 13(4):S35-9. PubMed ID: 8824685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of carotid atherosclerosis in hypertension: preliminary baseline data from the European Lacidipine Study on Atheroscelerosis (ELSA).
    Zanchetti A
    Blood Press Suppl; 1996; 4():30-5. PubMed ID: 8973780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertension, atherosclerosis and microalbuminuria in ELSA. European Lacidipine Study of Atherosclerosis.
    Ruilope LM; Rodicio JL
    Blood Press Suppl; 1996; 4():48-52. PubMed ID: 8973784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and incidence of the metabolic syndrome in the European Lacidipine Study on Atherosclerosis (ELSA) and its relation with carotid intima-media thickness.
    Zanchetti A; Hennig M; Baurecht H; Tang R; Cuspidi C; Carugo S; Mancia G
    J Hypertens; 2007 Dec; 25(12):2463-70. PubMed ID: 17984668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension and atherosclerosis.
    Ram CV
    Prim Care; 1991 Sep; 18(3):559-75. PubMed ID: 1946788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Third generation of calcium antagonists: focus on lacidipine].
    Sidorenko BA; Stetsenko TM; Preobrazhenskiĭ DV; Savchenko MV; Soplevenko AV; Shabaeva EN
    Kardiologiia; 2002; 42(12):81-90. PubMed ID: 12494025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline values but not treatment-induced changes in carotid intima-media thickness predict incident cardiovascular events in treated hypertensive patients: findings in the European Lacidipine Study on Atherosclerosis (ELSA).
    Zanchetti A; Hennig M; Hollweck R; Bond G; Tang R; Cuspidi C; Parati G; Facchetti R; Mancia G
    Circulation; 2009 Sep; 120(12):1084-90. PubMed ID: 19738145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of long-term antihypertensive treatment by clinic and ambulatory blood pressure: data from the European Lacidipine Study on Atherosclerosis.
    Mancia G; Parati G; Bilo G; Maronati A; Omboni S; Baurecht H; Hennig M; Zanchetti A
    J Hypertens; 2007 May; 25(5):1087-94. PubMed ID: 17414674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antihypertensive therapy. Can a calcium antagonist stop arteriosclerosis?].
    MMW Fortschr Med; 2001 May; 143(22):53. PubMed ID: 11460409
    [No Abstract]   [Full Text] [Related]  

  • 16. [ELSA Studies studies progression of atherosclerosis. Calcium antagonist arrests the process more than a beta-blocker].
    Einecke D
    MMW Fortschr Med; 2001 Jul; 143(26-27):6. PubMed ID: 11481923
    [No Abstract]   [Full Text] [Related]  

  • 17. The E.L.S.A. trial: protocol of a randomized trial to explore the differential effect of antihypertensive drugs on atherosclerosis in hypertension.
    Bond G; Dal Palú C; Hansson L; Magnani B; Mancia G; Neiss A; Rahn KH; Reid JL; Rodicio JL; Safar M
    J Cardiovasc Pharmacol; 1994; 23 Suppl 5():S85-7. PubMed ID: 7609514
    [No Abstract]   [Full Text] [Related]  

  • 18. Endothelial dysfunction, hypertension and atherosclerosis. A review of the effects of lacidipine.
    Haller H; Cosentino F; Lüscher TF
    Drugs R D; 2002; 3(5):311-23. PubMed ID: 12455152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-drug therapy and reduction of left ventricular mass in hypertension.
    Gottdiener JS
    Cardiologia; 1998 Nov; 43(11):1177-83. PubMed ID: 9922583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypertension in type 2 diabetic patients. Calcium antagonist supports the left heart].
    MMW Fortschr Med; 2001 Jun; 143(25):58. PubMed ID: 11469003
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.